Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Value of CD1B in Localised Prostate Cancer.

International journal of environmental research and public health - 27 Nov 2019

Lee Cheng-Hsueh, Chen Lih-Chyang, Yu Chia-Cheng, Lin Wen-Hsin, Lin Victor C, Huang Chao-Yuan, Lu Te-Ling, Huang Shu-Pin, Bao Bo-Ying

Abstract excerpt

Cluster of differentiation (CD) antigens are cell surface markers used to differentiate haematopoietic cell types. These antigens are present in various malignancies and are reportedly linked to patient prognosis; however, they have not been implemented as prostate cancer progression markers. Here, we aimed to assess the impact of genetic variation in haematopoietic cell CD markers on clinical outcomes in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antigens, CD1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Polymorphism, Single Nucleotide

Share to Predictive Value of Tests

Share to Proportional Hazards Models

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 31783478
DOI: 10.3390/ijerph16234723
PMCID: PMC6926967

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Value of CD1B in Localised Prostate Cancer.PMID 31783478Read ↗

Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study.Semantic proximity Read ↗

Prostate Cancer: Genetics, Epigenetics and the Need for Immunological BiomarkersSemantic proximity Read ↗

Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to PrognosisSemantic proximity Read ↗

Genomic Predictors of Outcome in Prostate CancerSemantic proximity Read ↗

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomySemantic proximity Read ↗

Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.Semantic proximity Read ↗

Genetic predisposition to early recurrence in clinically localized prostate cancer.Semantic proximity Read ↗

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.Semantic proximity Read ↗

CD24 is a genetic modifier for risk and progression of prostate cancer.Semantic proximity Read ↗

Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization studySemantic proximity Read ↗

Comparative analysis of genetic risk scores for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy.Semantic proximity Read ↗

An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.